ネオアンチゲン駆動のB細胞とCD4毛細血管のヘルパー細胞の協力により,抗腫瘍CD8T細胞の反応が促進される
Can Cui1, Jiawei Wang2, Eric Fagerberg1
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.
Cell
|December 1, 2021
まとめ
CD4 T卵泡ヘルパー (TFH) 細胞とB細胞の相互作用は,肺腺がんにおける抗腫瘍免疫を促進する. 腫瘍新抗原はTFH細胞の発達を促し,よりよい生存のためにCD8T細胞の機能を高めます.
科学分野:
- 免疫学
- 腫瘍学
- 癌 研究
背景:
- CD4 T卵泡ヘルパー (TFH) 細胞は,生殖中心 (GC) の形成のためのB細胞をサポートする.
- がん免疫におけるTFH-B細胞の相互作用の役割は,ほとんど定義されていない.
- 肺腺がん (LUAD) は,世界中でがんによる死亡の主な原因です.
研究 の 目的:
- 肺腺がん (LUAD) 免疫におけるTFH-B細胞相互作用の役割を調査する.
- 患者の生存に対するTFH-B細胞シグネチャの影響を調査する.
- TFH-B細胞媒介の抗腫瘍反応の背後にあるメカニズムを解明する.
主な方法:
- LUAD患者コホートにおけるTFHとGCB細胞の転写シグネチャーの分析
- 腫瘍新抗原を発現するネズミのLUADモデルの開発.
- TFH-B細胞の相互作用,IL-21の産生,およびCD8T細胞の機能の評価 in vivo.
主要な成果:
- TFHとGCB細胞シグネチャーの濃縮は,LUAD患者の生存率の改善と相関しています.
- 腫瘍特異のTFHとGCB細胞の相互作用は,IL-21と共に,腫瘍制御に不可欠である.
- TFH細胞の発達はB細胞と腫瘍新抗原に依存しています.
- TFH-B細胞の相互作用は,抗腫瘍CD8T細胞エフェクター機能を強化する.
結論:
- TFH-B細胞の相互作用は,LUADにおける抗腫瘍免疫の重要な構成要素である.
- 腫瘍新抗原は,TFH細胞の運命と機能の重要な調節体として作用する.
- TFH-B細胞軸とIL-21をターゲットにすることで,LUADに対する新しい治療戦略を提供することができる.
関連する概念動画
Tumor Immunotherapy
725
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
725
T Cell Activation and Clonal Selection
8.5K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
8.5K
Cytotoxic T Cells-mediated Immune Response
4.3K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
4.3K
T Cell Types and Functions
1.5K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.5K
B Cell Activation and Differentiation
9.5K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
9.5K
Cell-mediated Immune Responses
75.3K
Overview
75.3K


